Endothelin-antagonizing peptide
US5631222A · kind A · utility
1Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 1995 |
| Grant date | May 20, 1997 |
| Priority date | — |
| Expiry date | Feb 10, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a peptide compound represented by the following formula (I): EQU R.sup.1 -R.sup.2 -R.sup.3 -R.sup.4 -R.sup.5 -R.sup.6 -R.sup.7 -R.sup.8 -R.sup.9 -R.sup.10 -R.sup.11 -R.sup.12 -Phe-R.sup.14 -R.sup.15 -R.sup.16 -R.sup.17 -R.sup.18 -Ile-R.sup.20 -Z SEQ. ID NO. 64, (I) wherein R.sup.1-12, R.sup.14-18, and R.sup.20 are as defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.